Medications that are most effective may have a higher risk of adverse effects
Ongoing research and investigational therapies, such as GIP/GLP-1/glucagon triple agonists, may inform future strategies for sustainable weight loss after discontinuation of weight loss pharmacotherapy
PlexusDx provides ongoing clinical support throughout your adjustment phase, including check-ins at weeks 2, 4, and 8 to monitor your progress and address concerns early
Semaglutide and orforglipron act on the same single targetso this group may have maintained weight loss better after switching treatments, but they started with a less dramatic weight loss
It signals to your brain that youre full, slows digestion, and helps regulate insulin
Semaglutide under the brand names Ozempic and Wegovy, tirzepatide under the names Mounjaro and Zepbound, and other medications in this class have demonstrated meaningful results for weight management and blood sugar control that go beyond what most previous treatment options could offer
